Dossier
knee replacements
Coverage of knee replacements in the Nexus archive.
- STAT+: Pharmalittle: We’re reading about GLP-1 drugs and knees, FDA cell and gene therapy guidance, and more
Cigna will stop covering GLP-1 weight loss drugs like Wegovy and Zepbound in its employee health plan starting July 1, directing users to cash-pay options. A study suggests long-term use of GLP-1 drugs could reduce knee replacement risk by up to 5% over eight years. Prices for these drugs are declining in 2026 with new oral versions.
- Weight-loss drugs may prevent thousands of knee replacements, study suggests
Taking weight-loss drugs for at least three years may reduce the risk of knee replacements for patients with knee arthritis, according to a study. Globally, over 500 million people have osteoarthritis, with 14 million in the US and 5 million in the UK affected by knee arthritis. Over 120,000 knee replacements are performed annually in the UK.